Literature DB >> 12914869

Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).

Dirk C Felmeden1, Charles G C Spencer, Natali A Y Chung, Funmi M Belgore, Andrew D Blann, D Gareth Beevers, Gregory Y H Lip.   

Abstract

Increasing evidence points toward a prothrombotic state in hypertension and atherosclerosis, conditions associated with thrombosis-related complications, such as myocardial infarction and stroke. We hypothesized that this increased risk of thrombogenesis may be related to endothelial damage/dysfunction and abnormal angiogenesis, and thus, an increased risk of future cardiovascular disease. Thrombogenesis, endothelial damage/dysfunction, and angiogenesis can be assessed by measurement of tissue factor (TF), von Willebrand Factor (vWF), flow-mediated dilatation (FMD), and vascular endothelial growth factor (VEGF), respectively. To test this hypothesis, we measured TF, vWF, FMD, and VEGF in 76 patients with systemic hypertension (71 men; mean age 64; mean blood pressure 167/72 mm Hg), considered additional risk factors such as diabetes, and related them to the patient's 10-year cardiovascular and cerebrovascular risk score using the Framingham equation. Patients were compared with 48 healthy normotensive controls. In these patients, the effects of 6 months of intensified blood pressure and (where appropriate) lipid-lowering treatment were investigated. In our patients, TF, VEGF, and vWF levels were higher, but FMD was lower (all p <0.001) compared with the controls. All markers correlated with each other and with both cardiovascular and cerebrovascular risk scores (all p <0.001). After intensified blood pressure and hypercholesterolemia treatment, total cholesterol, blood pressure, TF, VEGF, and vWF levels all decreased, whereas FMD increased (all p <0.001). Thus, in subjects with hypertension and other risk factors, endothelial damage/dysfunction (and thus, atherogenesis), thrombogenesis, and angiogenesis are abnormal, correlate with overall cardiovascular risk, and importantly, can be related to each other in a "Birmingham Vascular Triangle." Furthermore, these processes are beneficially affected by intensive blood pressure and lipid treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914869     DOI: 10.1016/s0002-9149(03)00657-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Clinical role of von Willebrand factor in acute ischemic stroke.

Authors:  Marija Menih; Miljenko Križmarić; Tanja Hojs Fabjan
Journal:  Wien Klin Wochenschr       Date:  2017-04-13       Impact factor: 1.704

2.  Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.

Authors:  Jingjing Cai; Yuan Hong; Chunyan Weng; Chen Tan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-21       Impact factor: 4.733

3.  Role of the VEGF 936 gene polymorphism and VEGF-A levels in the late-term arteriovenous fistula thrombosis in patients undergoing hemodialysis.

Authors:  Ferhan Candan; Gürsel Yildiz; Mansur Kayataş
Journal:  Int Urol Nephrol       Date:  2014-04-20       Impact factor: 2.370

4.  Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site.

Authors:  Jin-an Jiao; Andrew B Kelly; Ulla M Marzec; Esperanza Nieves; Jorge Acevedo; Martin Burkhardt; Ana Edwards; Xiao-yun Zhu; Pierre-Andre Chavaillaz; Alice Wong; Jeffrey L Wong; Jack O Egan; Dean Taylor; Peter R Rhode; Hing C Wong
Journal:  Thromb Haemost       Date:  2009-10-26       Impact factor: 5.249

5.  The immediate effect of aerobic exercise on haemostatic parameters in patients with recently diagnosed mild to moderate essential hypertension.

Authors:  John Lekakis; Helen Triantafyllidi; Vasiliki Galea; Matina Koutroumbi; Theodoros Theodoridis; Christoforos Komporozos; Ignatios Ikonomidis; Vasiliki Christopoulou-Cokkinou; Dimitrios Th Kremastinos
Journal:  J Thromb Thrombolysis       Date:  2007-06-06       Impact factor: 2.300

Review 6.  Endothelial function in patients with atrial fibrillation.

Authors:  Ahsan A Khan; Graham N Thomas; Gregory Y H Lip; Alena Shantsila
Journal:  Ann Med       Date:  2020-01-10       Impact factor: 4.709

7.  Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats.

Authors:  Su Young Han; Emily Gray; Gillian Hughes; Colin H Brown; Daryl O Schwenke
Journal:  Pflugers Arch       Date:  2013-08-25       Impact factor: 3.657

8.  Coronary angiogenesis during experimental hypertension: is it reversible?

Authors:  Mohammad Zarei; Majid Khazaei; Mohammad Reza Sharifi; Ali Asghar Pourshanazari
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

Review 9.  The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man.

Authors:  Alessandra Del Fiorentino; Silvana Cianchetti; Alessandro Celi; Giulia Dell'Omo; Roberto Pedrinelli
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

Review 10.  The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.

Authors:  M Ekholm; T Kahan
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.